Dale Bredesen, MD, is internationally recognized as an expert in the mechanisms of neurodegenerative diseases such as Alzheimer's disease. He graduated from Caltech, then earned his MD from Duke University Medical Center. He served as chief resident in neurology at the University of California, San Francisco (UCSF) before joining Nobel laureate Stanley Prusiner's laboratory at UCSF as an NIH postdoctoral fellow. He has held faculty positions at UCSF, UCLA, and the University of California, San Diego. Dr. Bredesen directed the Development, Aging and Regeneration Program at Sanford Burnham Prebys before coming to the Buck Institute in 1998 as its founding president and CEO. He is the chief medical officer of MPI Cognition.